• H.R. 1038, Access to Life-Saving Medicine Act H.R. 1561, Enhancing Drug Safety and Innovation Act of 2007 H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 S. 1505, Affordable Biologics for Consumers ActS. 1695, Biologics Price Competition and Innovation Act of 2007 S. 2029, Physician Payments Sunshine Act of 2007 S. 596, Safe Internet Pharmacy Act of 2007 Drug Importation H.R.5629, Pathway for Biosimilars Act H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
• H.R. 2602, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H.R. 3162, Children's Health and Medicare Protection Act of 2007 Medicare "non-interference" provisions S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansionS. 2029, Physician Payments Sunshine Act of 2007 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare "non-interference" provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion S. 3101, Medicare Improvements for Patients and Providers Act of 2008

Duration: April 1, 2008 to January 1, 2009

General Issues: Pharmacy, Medicare/Medicaid, Health Issues

Spending: about $145,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: House of Representatives, U.S. Senate